carbon monoxide has been researched along with Hypercoagulability in 6 studies
Carbon Monoxide: Carbon monoxide (CO). A poisonous colorless, odorless, tasteless gas. It combines with hemoglobin to form carboxyhemoglobin, which has no oxygen carrying capacity. The resultant oxygen deprivation causes headache, dizziness, decreased pulse and respiratory rates, unconsciousness, and death. (From Merck Index, 11th ed)
carbon monoxide : A one-carbon compound in which the carbon is joined only to a single oxygen. It is a colourless, odourless, tasteless, toxic gas.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Cigarette smoking is associated with plasmatic hypercoagulability, and carbon monoxide has been demonstrated to enhance coagulation by binding to a fibrinogen-bound heme." | 7.77 | Redox-based thrombelastographic method to detect carboxyhemefibrinogen-mediated hypercoagulability. ( Arkebauer, MR; Nielsen, VG; Vosseller, K, 2011) |
| "Cigarette smoking is associated with plasmatic hypercoagulability, and carbon monoxide has been demonstrated to enhance coagulation by binding to a fibrinogen-bound heme." | 3.77 | Redox-based thrombelastographic method to detect carboxyhemefibrinogen-mediated hypercoagulability. ( Arkebauer, MR; Nielsen, VG; Vosseller, K, 2011) |
| "Morbid obesity is associated with significant thrombophilia." | 2.80 | Bariatric patients have plasmatic hypercoagulability and systemic upregulation of heme oxygenase activity. ( Boyle, PK; Galvani, CA; Matika, RW; Nielsen, VG; Steinbrenner, EB, 2015) |
| "Smoking cessation is an important factor in the primary and secondary prevention of cardiac events." | 2.43 | Smoking cessation in patients with coronary artery disease. ( Eisenberg, MJ; Ludvig, J; Miner, B, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nielsen, VG | 5 |
| Gharagozloo, F | 1 |
| Matika, RW | 2 |
| Kim, S | 1 |
| Zelman, EA | 1 |
| Steinbrenner, EB | 2 |
| Galvani, CA | 1 |
| Boyle, PK | 1 |
| Thompson, JL | 1 |
| Castro, AR | 1 |
| Chen, A | 1 |
| Henderson, J | 1 |
| Arkebauer, MR | 1 |
| Vosseller, K | 1 |
| Ludvig, J | 1 |
| Miner, B | 1 |
| Eisenberg, MJ | 1 |
1 review available for carbon monoxide and Hypercoagulability
| Article | Year |
|---|---|
Smoking cessation in patients with coronary artery disease.
Topics: Administration, Cutaneous; Administration, Inhalation; Administration, Oral; Atherosclerosis; Behavi | 2005 |
1 trial available for carbon monoxide and Hypercoagulability
| Article | Year |
|---|---|
Bariatric patients have plasmatic hypercoagulability and systemic upregulation of heme oxygenase activity.
Topics: Adult; Bariatric Surgery; Carbon Monoxide; Carboxyhemoglobin; Female; Heme Oxygenase (Decyclizing); | 2015 |
4 other studies available for carbon monoxide and Hypercoagulability
| Article | Year |
|---|---|
Thoracic tumor effects on plasmatic coagulation: role of hemeoxygenase-1.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Blood Coagulation; Carbon Monoxide; Carboxyhemoglobin; F | 2014 |
Heme oxygenase derived carbon monoxide and iron mediated plasmatic hypercoagulability in a patient with calcific mitral valve disease.
Topics: Calcinosis; Carbon Monoxide; Carboxyhemoglobin; Female; Heme Oxygenase (Decyclizing); Humans; Iron; | 2015 |
Sonoclot(®)-based method to detect iron enhanced coagulation.
Topics: Blood Coagulation; Carbon Monoxide; Humans; Iron; Sensitivity and Specificity; Thrombelastography; T | 2016 |
Redox-based thrombelastographic method to detect carboxyhemefibrinogen-mediated hypercoagulability.
Topics: Blood Coagulation; Calcium; Carbon Monoxide; Dose-Response Relationship, Drug; Elastic Modulus; Fibr | 2011 |